Mr James C. Fitzpatrick > Hughes Hubbard & Reed LLP > New York, United States > Lawyer Profile

Leveraging expertise throughout the country, including a particularly compelling East Coast and Midwest offering, Hughes Hubbard & Reed LLP is ‘very well-prepared to answer all kind of questions related to product liability matters’, irrespective of geographical location. The team is best-known for its  work in federally-regulated industries, and as well as its ‘stellar pharmaceuticals offering’, is also accomplished at handling matters relating to alleged damage caused by tobacco and speciality chemicals. Drawing upon trial and appellate litigation prowess, Kansas City-based partner James Berger  is adept at handling all aspects of complex litigation in multiple state and federal courts throughout the country; he continues to spearhead the firm’s efforts on behalf of tobacco company R.J.Reynolds in the Kent filter litigation. Best-known for their life sciences and medical devices expertise, New York-based practitioners Robb Patryk  and James C. Fitzpatrick co-head the overarching products liability and toxic tort offering.

Lauded for its ‘deep legal, regulatory, and scientific knowledge’, Hughes Hubbard & Reed LLP provides ‘unparalleled client service’ to clients, often working collaboratively with other counsel in a “virtual law firm” setting to defend pharma and medical device companies against high-profile mass tort claims. The firm has also gained a market-leading reputation for its ability to effectively co-ordinate cross-border litigation, providing ‘very efficient, smooth and productive communication and work’, as a result of its ‘close familiarity with multinationals’ culture and requirements as well as with foreign law firms’. James C. Fitzpatrick  and Charles W. Cohen  have been key to this success and have both developed ‘vast international experience in different jurisdictions’ over the years. They both also ‘have exceptional skills to present creative and strong arguments’, with Fitzpatrick, in particular, noted for his ‘cutting-edge abilities on the scientific aspects’, and ability to effectively develop strong arguments working with medical and science experts. Robb Patryk  co-heads the team with Fitzpatrick and as part of his broad product liability practice regularly handles pharma-related disputes.